Skip to main content
. Author manuscript; available in PMC: 2015 Jul 29.
Published in final edited form as: Clin Biochem. 2012 Jun 16;45(0):999–1011. doi: 10.1016/j.clinbiochem.2012.06.007

Table 2.

Body of evidence summary table: phlebotomy teams.

Study (Quality and Effect Size Ratings) Population/Sample Setting Time period Results (Blood Culture Contamination Rates)
Gander 2009
- Good
- Substantial
3,662 total venipuncture blood cultaaures - Emergency Dept (West):
Phlebotomists: 2,012
Non -phlebotomists: 1,650
Parkland Memorial Hospital, Dallas, TX; 968 bed tertiary care teaching hospital 12/2006–12/2007; 5mos. of a 13-mo. period Phlebotomists: 3.1%
Non-phlebotomists: 7.4%
OR = 2.51 (CI: 1.84 –3.43)
Sheppard 2008
- Good
- Substantial
2,854 total blood cultures-Emergency
Dept.: Phlebotomists: 278
Non-phlebotomists: 2,576 (include venipuncture and catheter)
Emory Crawford Long Hospita, Atlanta, GA; Academic Medical Center 3 months– no dates reported Phlebotomists: 1.1%
Non-phlebotomists: 5.0%
OR = 4.83 (CI: 1.53 –15.28)
Surdulescu 1998
- Fair
- Substantial
Venipuncture blood draws with prep kits; Sample size not reported;~6,900 total for 1995; from 1/93–10/93 approx. ½ phlebotomy team draws St. Luke’s Medical Center, Case Western Reserve University, Cleveland, OH; teaching hospital. 10 months 01/1993–10/1993 Phlebotomists: 2.6%
Non-phlebotomists: 5.6%
(p= 0.003) OR = 2.09 (CI: 1.68 –2.61)
Weinbaum 1997
-Good
- Substantial
1,164 total blood culture venipuncture draws with prep kits; adult general medical and surgical care
Phlebotomists: 956
Non-phlebotomists: 208
New York Medical Center Hospital of Queens, Flushing, NY; 487-bed community hospital No dates reported. Baseline: 3mos.; Intervention: 6 mos. Phlebotomists: 1.2%
Non-phlebotomists: 4.8%,
OR = 4.34 (CI: 1.82 –10.36)
Unpublished
Geisinger Wyoming Valley Hospital 2009
- Good
- Substantial
~7020 total blood cultures; 73% by phlebotomists; non-phlebotomist blood collections include venipuncture and catheter Geisinger Wyoming Valley Hospital; Wilkes-Barre PA 9 months (01/2009–09/2009) Phlebotomists: 1.5%
Non-phlebotomists: 4.3%
OR = 2.93 (CI: 2.13 –4.02)
BODY OF EVIDENCE RATINGS # Studies by Quality and Effect Size Ratings
4 Good/Substantial
1 Fair/Substantial
Consistency YES
Overall Strength HIGH

Bibliographic information for all studies is provided in Appendix C.